Free Trial

Humana (HUM) Competitors

Humana logo
$297.99 +0.73 (+0.25%)
Closing price 03:59 PM Eastern
Extended Trading
$297.81 -0.18 (-0.06%)
As of 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HUM vs. CI, CNC, ELV, MOH, UNH, SEM, JYNT, AEMD, PFE, and GILD

Should you be buying Humana stock or one of its competitors? The main competitors of Humana include Cigna Group (CI), Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), UnitedHealth Group (UNH), Select Medical (SEM), Joint (JYNT), Aethlon Medical (AEMD), Pfizer (PFE), and Gilead Sciences (GILD). These companies are all part of the "medical" sector.

Humana vs. Its Competitors

Humana (NYSE:HUM) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

Humana has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500. Comparatively, Cigna Group has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500.

In the previous week, Humana had 6 more articles in the media than Cigna Group. MarketBeat recorded 34 mentions for Humana and 28 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.50 beat Humana's score of 1.21 indicating that Cigna Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Humana
27 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Cigna Group
24 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Humana$117.76B0.30$1.21B$13.0322.87
Cigna Group$247.12B0.32$3.43B$18.3216.32

Humana presently has a consensus target price of $283.29, indicating a potential downside of 4.94%. Cigna Group has a consensus target price of $374.82, indicating a potential upside of 25.37%. Given Cigna Group's stronger consensus rating and higher probable upside, analysts plainly believe Cigna Group is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humana
0 Sell rating(s)
16 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.30
Cigna Group
0 Sell rating(s)
2 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.00

Cigna Group has a net margin of 1.92% compared to Humana's net margin of 1.28%. Cigna Group's return on equity of 18.80% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Humana1.28% 13.67% 4.85%
Cigna Group 1.92%18.80%5.02%

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.2%. Cigna Group pays an annual dividend of $6.04 per share and has a dividend yield of 2.0%. Humana pays out 27.2% of its earnings in the form of a dividend. Cigna Group pays out 33.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

92.4% of Humana shares are owned by institutional investors. Comparatively, 87.0% of Cigna Group shares are owned by institutional investors. 0.4% of Humana shares are owned by company insiders. Comparatively, 0.7% of Cigna Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Cigna Group beats Humana on 16 of the 20 factors compared between the two stocks.

Get Humana News Delivered to You Automatically

Sign up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HUM vs. The Competition

MetricHumanaMED IndustryMedical SectorNYSE Exchange
Market Cap$35.75B$41.65B$5.78B$21.32B
Dividend Yield1.19%68.83%3.95%3.51%
P/E Ratio22.8710.0331.2629.34
Price / Sales0.301.80464.6452.89
Price / Cash12.458.7137.7323.86
Price / Book1.962.3310.045.39
Net Income$1.21B$2.64B$3.27B$996.59M
7 Day Performance1.28%-0.47%3.17%3.12%
1 Month Performance28.86%10.66%4.34%2.97%
1 Year Performance-15.45%-33.59%44.12%12.83%

Humana Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HUM
Humana
4.1727 of 5 stars
$297.99
+0.2%
$283.29
-4.9%
-15.9%$35.75B$117.76B22.8765,680Positive News
Dividend Announcement
CI
Cigna Group
5 of 5 stars
$300.83
-1.2%
$374.82
+24.6%
-15.2%$80.26B$259.42B16.4173,500Positive News
Analyst Forecast
CNC
Centene
4.868 of 5 stars
$29.08
-1.1%
$42.20
+45.1%
-63.0%$14.29B$163.07B7.2060,500Trending News
Analyst Forecast
ELV
Elevance Health
4.8873 of 5 stars
$314.46
-0.7%
$413.81
+31.6%
-43.6%$70.70B$189.25B13.36104,200Positive News
MOH
Molina Healthcare
4.928 of 5 stars
$175.12
+0.4%
$242.91
+38.7%
-49.7%$9.48B$40.65B8.6218,000Positive News
Analyst Forecast
UNH
UnitedHealth Group
4.9429 of 5 stars
$305.30
-0.7%
$365.38
+19.7%
-48.3%$276.40B$400.28B13.22400,000Trending News
Analyst Forecast
Analyst Revision
SEM
Select Medical
4.9978 of 5 stars
$13.18
-1.8%
$20.25
+53.7%
-63.1%$1.63B$5.19B12.3944,100Positive News
JYNT
Joint
4.0274 of 5 stars
$10.82
+2.0%
$16.33
+51.0%
-4.7%$165.78M$53.45M-32.74320Positive News
High Trading Volume
AEMD
Aethlon Medical
2.5204 of 5 stars
$1.42
-10.9%
$56.00
+3,854.8%
-58.2%$3.65M$570K-0.1110
PFE
Pfizer
4.8806 of 5 stars
$25.16
-2.8%
$28.12
+11.8%
-13.0%$142.98B$63.63B13.3881,000Trending News
GILD
Gilead Sciences
4.974 of 5 stars
$114.20
-0.5%
$115.39
+1.0%
+47.9%$141.43B$28.86B22.7117,600Positive News

Related Companies and Tools


This page (NYSE:HUM) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners